logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Fuwei Xie

Zhengzhou Tobacco Research Institute of CNTC
H指数:26
被引数:1,868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of PD-1 inhibitors plus chemotherapy for advanced unresectable gastroesophageal cancer: a systematic review and meta-analysis of phase III randomized controlled trials

PD-1抑制剂联合化疗治疗晚期不可切除性胃肠癌的疗效与安全性：一项基于III期随机对照试验的系统评价和Meta分析

Frontiers in Oncology
IF3.3
2026-09-220
OAAI
CH Chenfeng Hua †; RZ Rui Zhang †; XM Xiuli Mo; QY Quanping Yan; CM Chengjie Ma; FX Fuwei Xie; YJ Yongliang Jia
A simple derivatization and highly sensitive gas chromatography-mass spectrometry method for the determination of glycidol and 2-/3-monochloropropanediol in heated tobacco product aerosol

一种简单衍生化和高灵敏度的气相色谱-质谱法，用于测定加热烟草产品气溶胶中的缩水甘油和2-/3-单氯丙二醇

Journal of Chromatography A
IF4
2025-08-210
PRE
Bing Wang; Fuwei Xie; Mantang Chen; Pingping Shang; Lining Pan; Huapeng Cui; Yaqiong Qin; Li Zhang; Jizhao Guo; Xiaobing Zhang; Cong Nie; Xiaoyu Wang; Shaofeng Liu
Asia subgroup overall survival and long-term follow-up results of the phase IIb HERIZON-BTC-01 study: Zanidatamab in previously treated human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC)

亚洲亚组总生存期和长期随访结果：IIb期HERIZON-BTC-01研究——Zanidatamab用于既往接受过治疗的表皮生长因子受体2（HER2）扩增的胆道癌（BTC）

ANNALS OF ONCOLOGY
IF65.4
2024-12-011
PRE
Oh, D-Y.; Sun, H.; Kim, J. W.; Choi, H. J.; Chang, H-M.; Bao, L.; Ying, J.; Xie, F.; Lee, M. A.; Seol, Y. M.; Wu, X.; Bao, Y.; Garfin, P.; Zhao, Y.; Fan, J.

研究方向

暂未获取到该数据
王
王晓玉
H 指数:61论文数:870被引数:1.3万
J
Jianping Xie
H 指数:26论文数:157被引数:1,611
X
Xiang Li
H 指数:27论文数:178被引数:2,441
H 指数:0论文数:63被引数:325
赵
赵阁
H 指数:34论文数:343被引数:5,391
K
Kejian Liu
H 指数:32论文数:217被引数:3,615
张
张书圣
H 指数:63论文数:695被引数:1.5万
M
Mantang Chen
H 指数:23论文数:120被引数:2,534
H
Huapeng Cui
H 指数:13论文数:73被引数:557
L
Lining Pan
H 指数:8论文数:33被引数:162